395 related articles for article (PubMed ID: 23670165)
1. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
2. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.
Logadottir Y; Hallsberg L; Fall M; Peeker R; Delbro D
Scand J Urol; 2013 Feb; 47(1):52-6. PubMed ID: 22775390
[TBL] [Abstract][Full Text] [Related]
3. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis.
Logadottir Y; Delbro D; Lindholm C; Fall M; Peeker R
Int J Urol; 2014 Apr; 21 Suppl 1():75-8. PubMed ID: 24807505
[TBL] [Abstract][Full Text] [Related]
4. Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate?
Sun Y; Fang Z; Ding Q; Zheng J
Neurourol Urodyn; 2014 Mar; 33(3):341-4. PubMed ID: 23744795
[TBL] [Abstract][Full Text] [Related]
5. ESSIC criteria for the diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC) and comparison with the NIDDK criteria.
Proaño A; Garde G; Garrido G; Mazza O
Arch Esp Urol; 2013 Mar; 66(2):206-14. PubMed ID: 23589598
[TBL] [Abstract][Full Text] [Related]
6. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
8. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
9. Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Logadottir Y; Delbro D; Fall M; Gjertsson I; Jirholt P; Lindholm C; Peeker R
J Urol; 2014 Nov; 192(5):1564-8. PubMed ID: 24813342
[TBL] [Abstract][Full Text] [Related]
10. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
11. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis.
Logadottir Y; Fall M; Kåbjörn-Gustafsson C; Peeker R
Scand J Urol Nephrol; 2012 Oct; 46(5):365-70. PubMed ID: 22607036
[TBL] [Abstract][Full Text] [Related]
13. Clinical Relevance of Bladder Histopathological Findings and Their Impact on Treatment Outcomes among Patients with Interstitial Cystitis/Bladder Pain Syndrome: An Investigation of the European Society for the Study of Interstitial Cystitis Histopathological Classification.
Jhang JF; Hsu YH; Jiang YH; Ho HC; Kuo HC
J Urol; 2021 Jan; 205(1):226-235. PubMed ID: 32856961
[TBL] [Abstract][Full Text] [Related]
14. Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
Morlacco A; Mancini M; Soligo M; Zattoni F; Calpista A; Vizzielli G; Patti R; Mandato FG; Barneschi AC; Zattoni F; Iafrate M; Dal Moro F;
Urology; 2020 Oct; 144():106-110. PubMed ID: 32619597
[TBL] [Abstract][Full Text] [Related]
15. Cystoscopy and bladder biopsies in patients with bladder pain syndrome carried out following ESSIC guidelines.
Wyndaele JJ; Van Dyck J; Toussaint N
Scand J Urol Nephrol; 2009; 43(6):471-5. PubMed ID: 19707951
[TBL] [Abstract][Full Text] [Related]
16. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?
Gamper M; Regauer S; Welter J; Eberhard J; Viereck V
J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361
[TBL] [Abstract][Full Text] [Related]
17. YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis.
Richter B; Roslind A; Hesse U; Nordling J; Johansen JS; Horn T; Hansen AB
Histopathology; 2010 Sep; 57(3):371-83. PubMed ID: 20840668
[TBL] [Abstract][Full Text] [Related]
18. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
[TBL] [Abstract][Full Text] [Related]
19. Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC).
Neuhaus J; Schulte-Baukloh H; Stolzenburg JU; Speroni di Fenizio P; Horn LC; Rüffert H; Hartenstein S; Burger M; Schulze M; Schwalenberg T
World J Urol; 2012 Oct; 30(5):693-700. PubMed ID: 21969132
[TBL] [Abstract][Full Text] [Related]
20. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.
Furuta A; Yamamoto T; Suzuki Y; Gotoh M; Egawa S; Yoshimura N
Int Urogynecol J; 2018 Jul; 29(7):961-966. PubMed ID: 29372285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]